< Back to scientific publications

Magazine 14.17

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First ItalianζoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Date: 2021

Scope of interest: Epilepsy




You may also be interested in:

Magazine 7.14

Ictal epileptic headache as “subtle” symptom in generalized idiopathic epilepsy

Authors: Fanella M, Fattouch J, Casciato S, Lapenta L, Morano A, Aegean G, Manfredi M, Prencipe M, Giallonardo AT, Di Bonaventura

Date: 2012

Scope of interest: Epilepsy


Read details
Magazine 7,093

Repaglinide administration improves brachial reactivity in type 2 diabetic patients.

Authors: Manzella D, Grella R, Abbatecola AM, Paolisso G.

Date: 2005

Scope of interest: diabetes


Read details
Magazine 7.19

Switch From Originator to Equivalent Drug in the Era of Generic Antiepileptic Drugs: Study of Keppra Versus Epitiram Clinical Equivalence.

Authors: Fanella M, Morano A, Fattouch J, Albini M, Basili LM, Casciato S, Manfredi M, Giallonardo AT, Di Bonaventura C.

Date: 2017

Scope of interest: Epilepsy


Read details